TITLE

FDA's proposed rule for OTC sunscreens includes UVA ratings

AUTHOR(S)
Levy, Sandra
PUB. DATE
September 2007
SOURCE
Drug Topics;9/17/2007, Vol. 151 Issue 18, p60
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on a proposed rule issued by the U.S. Food and Drug Administration (FDA) that sets standards for formulating, testing and labeling over-the-counter sunscreens products with ultraviolet A (UVA) and B (UVB) protection. The proposed changes include: UVA protection will be clearly identified on the front of sunscreen products by the term UVA followed by one, two, three or four stars, a warning is required on sunscreens informing consumers that UV exposure increases the risk of skin cancer, premature skin aging and other skin damage and the UVA rating will be determined by conducting a laboratory test and a test on people. The agency is soliciting comments on appropriate ways to determine the SPF value for novel sunscreen forms.
ACCESSION #
27022416

 

Related Articles

  • New Rules and Regulations for Sunscreen Labels. Thornfeldt, Carl // Skin, Inc.;Aug2012, Vol. 24 Issue 8, p56 

    The article discusses the changes to the U.S. Food and Drug Administration's (FDA) regulation on how sunscreens are labeled. It states that the FDA considers sunscreens as over-the-counter drugs and wants to simplify the message that consumers get in the marketplace as most do not understand the...

  • Sunny skies ahead: Prepping for sunscreen questions. Haskell, Yennie; Krinsky, Daniel L. // Pharmacy Today;Mar2012, Vol. 18 Issue 3, p44 

    The article focuses on sunscreen products in the U.S. It offers information on the properties of sunscreen products which are divided into physical sunscreen that protects the skin from sunlight and chemical sunscreens that prevent the penetration ultra-violet (UV) rays into the epidermis. It...

  • Broad-spectrum knowledge. Guttman, Cheryl // Dermatology Times;Jul2008, Vol. 29 Issue 7, p42 

    The article reports that it is important for dermatologists and consumers in the U.S. to understand various methodologies used for testing and rating sunscreen efficacy, as well as their limitations. Sunscreens are labeled with a sun protection factor rating that indicates the level of...

  • Encouraging updates: New sunscreen labeling represents step forward in improving photoprotection. Krader, Cheryl Guttman // Dermatology Times;Feb2012, Vol. 33 Issue 2, p30 

    The article offers the insights of doctor Vincent A. DeLeo on the new testing and labeling regulations for sunscreens issued by the U.S. Food and Drug Administration (FDA) in June 2011. Doctor DeLeo states that the sun protection factor (SPF) will be the only number that will be seen in the...

  • Labeling and Effectiveness Testing; Sunscreen Drug Products for Over-the- Counter Human Use; Delay of Compliance Dates. Kux, Leslie // Federal Register (National Archives & Records Service, Office of;5/11/2012, Vol. 77 Issue 92, p27591 

    The article reports on a final rule issued by the U.S. Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services regarding delaying of compliance dates for over-the-counter sunscreen drug products. This rule has been issued as these drugs did not meet the labeling...

  • Over-the-Counter Medications. Brogdon, Dennise // Hughston Health Alert;Winter2007, Vol. 19 Issue 1, p7 

    The article provides information on the importance of reading the label on over-the-counter (OTC) medication. The Drug Facts label will provide consumers as much information as possible to make the right decision before taking a medication or giving it to a family member. The new label which was...

  • The ABCs of OTCs. Scheller, Melanie // Current Health 2;Dec97, Vol. 24 Issue 4, p19 

    Presents information about over-the-counter (OTC) drugs. United States Food and Drug Administration's (FDA) role in selling OTC; Dangers of OTC medications; Proposal of standardized product label regulations by the FDA. INSETS: Top OTC conditions.;Herbal hype..

  • Improving Dose Content Uniformity Testing for MDIs and DPIs. Tuckwell, Jon; Sewell, Roger // Pharmaceutical Technology Europe;Jan2003, Vol. 15 Issue 1, p39 

    Discusses a drug content uniformity test that allows the quality of a batch of drug product to be determined accurately, using a suitable number of samples for the quality of the batch. Application of the Bayesian Inference to the test's development; Comparison with the test used by the U.S....

  • Harmonizing Standards and Specifications.  // Pharmaceutical Technology Europe;May2002, Vol. 14 Issue 5, p17 

    Focuses on product specifications during drug development and the corresponding standards imposed by the U.S. Food and Drug Administration. Initial drug specification testing; Discussion on the shelf-life of pharmaceutical product; Dissolution and disintegration test of drugs. INSET: ICH update.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics